脂肪酸結(jié)合蛋白1(FABP1)重組蛋白
Recombinant Fatty Acid Binding Protein 1 (FABP1)
FABP-1; FABPL; L-FABP; LFABP; Liver-type fatty acid-binding protein; Fatty Acid Binding Protein 1, Liver
- 編號(hào)RPB566Hu01
- 物種Homo sapiens (Human，人)相同的名稱，不同的物種。
- 來(lái)源原核表達(dá)
- 宿主E.coli
- 內(nèi)毒素水平<1.0EU/µg(LAL法測(cè)定)
- 亞細(xì)胞定位細(xì)胞質(zhì), 染色體
- 預(yù)測(cè)分子量15.3kDa
- 實(shí)際分子量13kDa(差異分析請(qǐng)參閱說(shuō)明書(shū))
- 片段與標(biāo)簽Ser2~Ile127 with N-terminal His Tag
- 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 97%
- 等電點(diǎn)7.1
- 應(yīng)用Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請(qǐng)參見(jiàn)活性蛋白。 - 下載英文說(shuō)明書(shū) 中文說(shuō)明書(shū)
- 規(guī)格10μg50μg200μg1mg5mg
- 價(jià)格¥ 768¥ 1920¥ 3840¥ 11520¥ 28800
- 欲了解實(shí)際交易價(jià)格和更多情況，請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
產(chǎn)品包裝(模擬)
產(chǎn)品包裝(模擬)
Figure. Gene Sequencing (Extract)
Figure. SDS-PAGE
通過(guò)ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
序列
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲(chǔ)存
避免反復(fù)凍融。2-8°C不超過(guò)一個(gè)月，-80°C不超過(guò)12個(gè)月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時(shí)，沒(méi)有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲(chǔ)，損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPB566Hu01 | 脂肪酸結(jié)合蛋白1(FABP1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAB566Hu01 | 脂肪酸結(jié)合蛋白1(FABP1)多克隆抗體 | WB,IHC |
| PAB566Hu02 | 脂肪酸結(jié)合蛋白1(FABP1)多克隆抗體 | IHC |
| LAB566Hu71 | 脂肪酸結(jié)合蛋白1(FABP1)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| LAB566Hu81 | 脂肪酸結(jié)合蛋白1(FABP1)多克隆抗體(異硫氰酸熒光素標(biāo)記) | WB; IHC; ICC; IF. |
| MAB566Hu22 | 脂肪酸結(jié)合蛋白1(FABP1)單克隆抗體 | WB,IHC,ICC/IF |
| MAB566Hu23 | 脂肪酸結(jié)合蛋白1(FABP1)單克隆抗體 | IHC |
| MAB566Hu21 | 脂肪酸結(jié)合蛋白1(FABP1)單克隆抗體 | WB,IHC |
| LAB566Hu82 | 脂肪酸結(jié)合蛋白1(FABP1)單克隆抗體(異硫氰酸熒光素標(biāo)記) | WB; IHC; ICC; IF. |
| LAB566Hu72 | 脂肪酸結(jié)合蛋白1(FABP1)單克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| HEB566Hu | 脂肪酸結(jié)合蛋白1(FABP1)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法,高敏型) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| WEB566Hu | 脂肪酸結(jié)合蛋白1(FABP1)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法,寬范圍) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| SEB566Hu | 脂肪酸結(jié)合蛋白1(FABP1)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMB566Hu | 脂肪酸結(jié)合蛋白1(FABP1)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
| PSB566Hu01 | 脂肪酸結(jié)合蛋白1(FABP1)抗體對(duì) | ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays. |
| KSB566Hu01 | 脂肪酸結(jié)合蛋白1(FABP1)檢測(cè)試劑盒DIY材料(酶聯(lián)免疫吸附試驗(yàn)法) | 自己動(dòng)手制作ELISA試劑盒的主要材料 |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| J Korean Med Sci. | Acute Kidney Injury after Using Contrast during Cardiac Catheterization in Children with Heart Disease[Pubmed:25120320] |
| Cryobiology.? | Ex vivo use of a Rho-kinase inhibitor during renal preservation improves graft function upon reperfusion[Pubmed:25555715] |
| Clin Transl Sci | Controlled Rewarming after Hypothermia: Adding a New Principle to Renal Preservation[PubMed: 26053383] |
| SAGE journals | The role of serum I-FABP concentration in assessment of small intestine mucosa among HIV-infected patients[Content: Early] |
| Transplant International | Kidney transplantation after oxygenated machine perfusion preservation with Custodiol‐N solution[PubMed: 25882869] |
| European?Journal of?Clinical?Investigation | Prediction of renal function upon reperfusion by ex situ controlled oxygenated rewarming[pubmed:27718228] |
| Journal of?Clinical?and Diagnostic?Research? | The Importance of Liver-Fatty Acid Binding Protein in Diagnosis of Liver Damage in Patients with Acute Hepatitis[pubmed:28571184] |
| Annals of Nutrition and Metabolism | Plasma Free Fatty Acids and their Binding Proteins in Preterm Infants[Pubmed:30045009] |
| Scandinavian Journal of?Clinical?and Laboratory Investigation | Isolated kidney perfusion: the influence of pulsatile flow[Pubmed:29301417] |
| International Journal of Medical Sciences | Circulating fatty acid-binding protein 1 (FABP1) and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus[Pubmed: 32038102] |
| International Journal of Medical Sciences | FABP1 and FABP2 as markers of diabetic nephropathy[Pubmed: 32922200] |
| Archives of Clinical and Biomedical Research | Profile of Intestinal Barrier Functional Markers in Italian Patients with Diarrhea-Predominant IBS: Preliminary Data from a Low-FODMAPs diet Trial[] |
| Antioxidants | The Effects of Beverage Intake after Exhaustive Exercise on Organ Damage, Inflammation and Oxidative Stress in Healthy Males[34071378] |
| antioxidants | TCA Cycle and Fatty Acids Oxidation Reflect Early Cardiorenal Damage in Normoalbuminuric Subjects with Controlled Hypertension[34356333] |
| Association of plasma fatty acid-binding protein 3 with estimated glomerular filtration rate in patients with type 2 diabetes mellitus[34975301] |